Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I have added the question to the Q & A portal of Meet the Company. I'm sure they will cover these areas off comprehensively and update us anyhow but have uploaded the following just the same:-
Can you update us please regarding which Project Is Likely to License First? On your website you previous stated: -
“VAL201 has completed a Phase 1/2 clinical trial, so is required to complete Phase 2 and 3 before market authorisation can be considered – the timeline for this will be dependent on the design of those trials”
“VAL301 is at preclinical stage, so requires all three clinical phases of development”
“VAL401 has a shorter route to market due to the nature of it as a reformulated generic drug, and requires at least one further clinical trial (depending on size and results) before market authorisation could be considered”
Therefore, of these three pipeline products, VAL401 can be considered furthest along the development pipeline. However, the timing of market authorisation is difficult to predict, especially as it is controlled by a third party.
Since then, we understand things have advanced somewhat, the Japanese partner working on Val301 has been involved for 17mths now, can you update on their progress?
Are we now closer to any form of market authorisation for Val 401, typically how long on average do they tend to take?
Thanks in advance
I never buy on terms, that is risky if you haven't the funds to back it up.
I remember when i was much younger firms like TD Waterhouse were allowing T3 to T20 at premiums and traders were using them for that purpose but the mms know.
I mean if i was an MM and wanted to be ruthless i could just widen the spread or lower the bid three days later and keep bag the profits if they don't pay up - probably goes on.
Pork's
Thanks RB - useful to know.
You can buy stock on a loan basis where you have T 3. = 3 days to pay for it t5 etc up to t10 or even t20 back in the days when I first started the longer you take the bigger the premium even then you can roll them over once after that.ie do it all again.
Best you to buy on t1 you can get your fingers burnt otherwise.
Rightback - could you explain what you mean by T3 traders pay up? Thanks in advance!
The current or the mid price is the actual price. 26p will hold and we should move up from here. We are finding some big buyers here. Someone just took 68,193 (£18,000). Few more of this then we will be close to 28/29p.
The big reward in this game goes to the most patient. If Suzy does well with VAL201 then I'll be here for a long, long time. I want to see it through to the end.
im hoping this is our new resistance level at 25 or 26p
Also T3 from Friday today traders pay up or leave day.
looks like my timing was out dam lol
When I buy stocks in AIM i buy in small blocks through out the day. This way i get a good average price if its down day. If its up day i'll be helping to push the price higher. Its a win win for me.
The 5000 sells i feel are deliberate sells to try to create a dip. But MM know this game better then anyone of us so they will puch it back up quickly when they see the buyers coming.
was hoping to grab them a little cheaper should have bought them yesterday but i was so busy didnt get a chance never mind not going to squable over a few pennies
@Defiant-one
Good call, this will rally towards 40p fairly quick i think
Great to offload a few more weak hands yesterday, perfect, a few less that could hold us back at the 40p point if news hasn't dropped by then on the first licensing deal
Looking forward to the presentation, superb
Pork's
just bought another 38k
It is worth noting the meeting is aimed at new investors as well. Will Cenkos bring a crowd to the meeting? I suspect so. We could see some large buys after this meeting .
I'm sure they will all want to see Suzy secure at least one deal otherwise it will not look good. Deal or big buys coming in during the next few days. All set up for a big rise ahead.
There we go, now let’s see if we can hold these blue days into news.
Morning all
Back to blue today !
L2’s
2 v 1 & 10k v 5k
2 Vs 1@26.5
We should move from this support!
The question we should all be asking is can we take out the recent highs (31p)?
Only few days left until the meeting. Still no deal. What will Suzy say?
Or will a deal drop Thursday or next Monday and lead us to the meeting all in a positive mood. TIme will tell hopefully move back to 30 today in anticipation. EIther way we are coming to the end of the year and a deal should be very close.
Incidentally, as pointed out the updated website looks great:-
https://www.valirx.com/ and now also a fantastic resource for shareholders with our own section
Nice clear graphics as well on the Products pipeline page illustrating how far along they are.
https://www.valirx.com/our-pipeline
I really like this, once they get the first deal over the line they should be in a position to add more projects so this will be a simple snap shot way at a glace, to see the progress. What a great design.
Anyhow, on the shareholder Q&A section found here:-
https://www.valirx.com/shareholder-communications
I was actually surprised to read that VAL401 has a shorter route to market due to the nature of it being a reformulated generic drug.
So you never know, we talk a lot about VAL201 and VAL301 but it could actually be VAL401 that’s first over the line.
Exciting times.
Will be interested to hear what Suzy has to say at the presentation next Tuesday. Looking forward to it.
Good luck guys, all to play for here…
Pork’s